ClinConnect ClinConnect Logo
Search / Trial NCT05958550

A Risk Prediction Model for Hypothermia After Laparoscopic Gastrointestinal Tumor Surgery

Launched by RENJI HOSPITAL · Jul 20, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to predict which patients may develop hypothermia after undergoing laparoscopic surgery for gastrointestinal tumors, such as cancers of the stomach, colon, and small intestine. Hypothermia, or a dangerously low body temperature, can lead to complications after surgery, making it important to identify patients who are at a higher risk. Researchers will use different methods, including advanced computer algorithms, to create models that help identify these high-risk patients and find ways to prevent hypothermia.

To participate in the trial, you need to be at least 18 years old and scheduled for specific types of laparoscopic surgery under general anesthesia. However, if you have a fever or low body temperature before the surgery, or if you have other specific health issues, you may not be eligible to join. If you participate, you can expect to help researchers understand how to better predict and prevent hypothermia, potentially improving outcomes for future patients undergoing similar surgeries. The study is currently not yet recruiting participants, but it aims to provide valuable insights for future research in this area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The types of surgery included laparoscopic radical gastrectomy for gastric cancer, duodenal cancer, colon cancer, rectal cancer and small bowel cancer. Age ≥ 18 years ; the anesthesia method was general anesthesia ; elective surgery.
  • Exclusion Criteria:
  • Patients with abnormal body temperature such as fever and hypothermia before operation ; patients who need low temperature to protect organs during operation ; patients who were converted to laparotomy during the operation ; a clear diagnosis of sweat gland dysfunction ; patients with external auditory canal active disease ; reject participants.

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported